Cargando…

Role of Genetic Changes in the Progression of Cardiovascular Diseases

This review aims to investigate the role of genetic changes in the development of cardiovascular diseases [CVD]. Oxidation of Low density Lipoprotein (LDL) and mutations in LDL receptors gene are a trigger for numerous of atherogenic events. Also, endothelial nitric oxide synthase (eNOS) plays an im...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sheweita, S. A., Baghdadi, H., Allam, A. R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Master Publishing Group 2011
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3614847/ https://www.ncbi.nlm.nih.gov/pubmed/23675242

Ejemplares similares

Novel Study on N-Nitrosamines as Risk Factors of Cardiovascular Diseases
por: Sheweita, Salah A., et al.
Publicado: (2014)

Changes in Oxidative Stress and Antioxidant Enzyme Activities in Streptozotocin-Induced Diabetes Mellitus in Rats: Role of Alhagi maurorum Extracts
por: Sheweita, S. A., et al.
Publicado: (2016)

Drug-Metabolizing Enzymes and Metabolic Diseases: Role of Antioxidants
por: Sheweita, Salah A., et al.
Publicado: (2016)

Erectile Dysfunction Drugs Changed the Protein Expressions and Activities of Drug-Metabolising Enzymes in the Liver of Male Rats
por: Sheweita, Salah A., et al.
Publicado: (2016)

Erectile dysfunction drugs altered the activities of antioxidant enzymes, oxidative stress and the protein expressions of some cytochrome P(450) isozymes involved in the steroidogenesis of steroid hormones
por: Sheweita, Salah A., et al.
Publicado: (2020)

Letrozole and zoledronic acid changed signalling pathways involved in the apoptosis of breast cancer cells
por: Sheweita, Salah A., et al.
Publicado: (2020)

Tramadol-induced hepato- and nephrotoxicity in rats: Role of Curcumin and Gallic acid as antioxidants
por: Sheweita, Salah A., et al.
Publicado: (2018)

Research progress on the role of ferroptosis in cardiovascular disease
por: Li, Han, et al.
Publicado: (2022)

Progressing Insights into the Role of Dietary Fats in the Prevention of Cardiovascular Disease
por: Zock, Peter L., et al.
Publicado: (2016)

Molecular Mechanisms Contributing Bacterial Infections to the Incidence of Various Types of Cancer
por: Sheweita, Salah A., et al.
Publicado: (2020)

Role of the Cysteinyl Leukotrienes in the Pathogenesis and Progression of Cardiovascular Diseases
por: Colazzo, Francesca, et al.
Publicado: (2017)

Analysis of genetic copy number changes in cervical disease progression
por: Policht, Frank A, et al.
Publicado: (2010)

The Impact of Traditional Cardiovascular Risk Factors on Cardiovascular Outcomes in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
por: Baghdadi, Leena R., et al.
Publicado: (2015)

Role of asymptomatic hyperuricemia in the progression of chronic kidney disease and cardiovascular disease
por: Waheed, Yousuf, et al.
Publicado: (2021)

Genetic insights into resting heart rate and its role in cardiovascular disease
por: van de Vegte, Yordi J., et al.
Publicado: (2023)

Association of Cardiovascular Risk Burden With Risk and Progression of Disability: Mediating Role of Cardiovascular Disease and Cognitive Decline
por: Cui, Kaiwang, et al.
Publicado: (2020)

Marginal role for 53 common genetic variants in cardiovascular disease prediction
por: Morris, Richard W, et al.
Publicado: (2016)

Oxidative Stress Alleviation by Sage Essential Oil in Co-amoxiclav induced Hepatotoxicity in Rats
por: El-Hosseiny, L. S., et al.
Publicado: (2016)

Erectile dysfunction drugs and oxidative stress in the liver of male rats
por: Sheweita, Salah, et al.
Publicado: (2015)

Bioinformatics and System Biological Approaches for the Identification of Genetic Risk Factors in the Progression of Cardiovascular Disease
por: Barua, Joy Dip, et al.
Publicado: (2022)

Protective Effects of Essential Oils as Natural Antioxidants against Hepatotoxicity Induced by Cyclophosphamide in Mice
por: Sheweita, Salah A., et al.
Publicado: (2016)

Genetics of Cardiovascular Disease
por: Stavljenic-Rukavina, Ana
Publicado: (2003)

Genetics in Cardiovascular Disease
por: Hajar, Rachel
Publicado: (2020)

Oral dysbacteriosis in type 2 diabetes and its role in the progression to cardiovascular disease
por: Nabee, Ziad, et al.
Publicado: (2017)

Genetics and tailored therapy in cardiovascular disease
por: Doevendans, P. A., et al.
Publicado: (2011)

Mitochondrial Quality Control in Cardiomyocytes: A Critical Role in the Progression of Cardiovascular Diseases
por: Fan, Hualin, et al.
Publicado: (2020)

Progress in research on the role of exosomal miRNAs in the diagnosis and treatment of cardiovascular diseases
por: Xu, Jinyu, et al.
Publicado: (2022)

Correction to: Association of Cardiovascular Risk Burden With Risk and Progression of Disability: Mediating Role of Cardiovascular Disease and Cognitive Decline
Publicado: (2020)

Genetics of Hypertension and Cardiovascular Disease
por: Katsuya, Tomohiro, et al.
Publicado: (2011)

Genetic susceptibility to cardiovascular disease and risk of dementia
por: Karlsson, I K, et al.
Publicado: (2017)

Prognostic significance of COVID-19 MSCT chest findings on short-term disease progression
por: Faheem, Mohamed H., et al.
Publicado: (2022)

Research progress of ghrelin on cardiovascular disease
por: Yuan, Ming-Jie, et al.
Publicado: (2021)

Current progress of ferroptosis in cardiovascular diseases
por: Zhang, Jie, et al.
Publicado: (2023)

Research progress of quercetin in cardiovascular disease
por: Zhang, Weiwei, et al.
Publicado: (2023)

Genetic Markers of Cardiovascular Disease in Rheumatoid Arthritis
por: Rodríguez-Rodríguez, Luis, et al.
Publicado: (2012)

The Role of Mitochondria in Cardiovascular Diseases
por: Poznyak, Anastasia V., et al.
Publicado: (2020)

Cardiovascular disease: The rise of the genetic risk score
por: Knowles, Joshua W., et al.
Publicado: (2018)

Editorial: Safety of Polyphenolic Compounds and Their Role in Cardiovascular Diseases
por: Ahmed, Lamiaa A., et al.
Publicado: (2022)

Progression of Renal Dysfunction in Patients with Cardiovascular Disease
por: Hirata, Yasunobu, et al.
Publicado: (2008)

Racial Differences and Contributory Cardiovascular and Non-Cardiovascular Risk Factors Towards Chronic Kidney Disease Progression
por: Choi, Yuni, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vgr6mj59rbp5nhv55qjjn7sbor